Botanix Pharmaceuticals
(OTC) BXPHF
Botanix Pharmaceuticals Financials at a Glance
Market Cap
$65.95M
Revenue (TTM)
A$23.98M
Net Income (TTM)
-A$127.98M
EPS (TTM)
-$0.03
P/E Ratio
-0.80
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$0.02
Volume
5,000
Open
$0.02
Price
$0.02
Volume
5,000
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.01 - $0.29
Estimated Earnings Date
Aug 28, 2026
Dividend
$0.00
Beta (Volatility)
0.34 (Low)
Price
$0.02
Volume
5,000
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.01 - $0.29
Estimated Earnings Date
Aug 28, 2026
BXPHF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Botanix Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Howie McKibbon, PharmD
Website
www.botanixpharma.comHeadquarters
Leederville, WA 6007, AU
BXPHF Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-122%
Return on Capital
-1%
Return on Assets
-90%
Earnings Yield
-1.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$65.95M
Shares Outstanding
2.73B
Volume
5.00K
Avg. Volume
21.10K
Financials (TTM)
Gross Profit
A$2.32M
Operating Income
-A$86.34M
EBITDA
-A$82.16M
Operating Cash Flow
-A$78.58M
Capital Expenditure
-A$1.05M
Free Cash Flow
-A$79.63M
Cash & ST Invst.
A$64.97M
Total Debt
A$32.11M
Botanix Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$16.50M
+4265.7%
Gross Profit
-A$28.75M
-850.5%
Gross Margin
-1.74%
N/A
Market Cap
$65.95M
N/A
Market Cap/Employee
$6.00M
N/A
Employees
11
N/A
Net Income
-A$33.18M
-506.9%
EBITDA
-A$32.42M
-1075.1%
Quarterly Fundamentals
Total Cash
A$31.60M
+72.6%
Total Debt
A$30.04M
N/A
Accounts Receivable
A$5.70M
+2496.0%
Inventory
A$27.50M
+778.0%
Long Term Debt
A$16.91M
N/A
Short Term Debt
A$13.13M
N/A
Return on Assets
-89.99%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
-A$32.63M
-76.0%
Operating Cash Flow
-A$32.63M
-767.7%